Advertisement

Syphilis and HIV

  • Natalia Mendoza
  • Adriana Motta
  • Brenda L. Pellicane
  • Parisa Ravanfar
  • Stephen K. Tyring
Chapter

Abstract

The incidence of syphilis has decreased since the introduction of penicillin and subsequent preventive measures. With the emergence of human immunodeficiency virus (HIV), syphilis has resurged as a significant disease. Diagnosis of syphilis is further complicated by the vast array of clinical manifestations due to coinfection with HIV. It is crucial to identify its clinical manifestations, diagnosis, and treatment in order to avoid its complicationsin patients coinfected with HIV. This chapter includes the epidemiology, clinical manifestations, diagnosis, and treatment of coinfection of syphilis andHIV.

Keywords

Human Immunodeficiency Virus Human Immunodeficiency Virus Patient Human Immunodeficiency Virus Infected Patient Venereal Disease Research Laboratory Benzathine Penicillin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Stevenson, J., Heath, M.: Syphilis and HIV infection: an update. Dermatol. Clin. 24(4), 497–507 (2006). viPubMedCrossRefGoogle Scholar
  2. 2.
    Zetola, N.M., Engelman, J., Jensen, T.P., Klausner, J.D.: Syphilis in the United States: an update for clinicians with an emphasis on HIV coinfection. Mayo Clin. Proc. 82(9), 1091–1102 (2007)PubMedCrossRefGoogle Scholar
  3. 3.
    Buckley, H.B.: Syphilis: a review and update of this ‘new’ infection of the ‘90s. Nurse Pract. 25(8), 9–32 (1992)Google Scholar
  4. 4.
    Chesson, H.W., Dee, T.S., Aral, S.O.: AIDS mortality may have contributed to the decline in syphilis rates in the United States in the 1990s. Sex. Transm. Dis. 30(5), 419–424 (2003)PubMedCrossRefGoogle Scholar
  5. 5.
    Lautenschlager, S.: Cutaneous manifestations of syphilis: recognition and management. Am. J. Clin. Dermatol. 7(5), 291–304 (2006)PubMedCrossRefGoogle Scholar
  6. 6.
    Nicoll, A., Hamers, F.F.: Are trends in HIV, gonorrhoea, and syphilis worsening in western Europe? BMJ (Clinical research ed) 324(7349), 1324–1327 (2002)CrossRefGoogle Scholar
  7. 7.
    Peterman, T.A., Heffelfinger, J.D., Swint, E.B., Groseclose, S.L.: The changing epidemiology of syphilis. Sex. Transm. Dis. 32(10 Suppl), S4–S10 (2005)PubMedGoogle Scholar
  8. 8.
    Couturier, E., Michel, A., Janier, M., Dupin, N., Semaille, C.: Syphilis surveillance in France, 2000–2003. Euro Surveill. 9(12), 8–10 (2004)PubMedGoogle Scholar
  9. 9.
    Rottingen, J.A., Cameron, D.W., Garnett, G.P.: A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex. Transm. Dis. 28(10), 579–597 (2001)PubMedCrossRefGoogle Scholar
  10. 10.
    Buchacz, K., Patel, P., Taylor, M., et al.: Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS (London, England) 18(15), 2075–2079 (2004)CrossRefGoogle Scholar
  11. 11.
    Zeltser, R., Kurban, A.K.: Syphilis. Clin. Dermatol. 22(6), 461–468 (2004)PubMedCrossRefGoogle Scholar
  12. 12.
    Scott, C.M., Flint, S.R.: Oral syphilis–re-emergence of an old disease with oral manifestations. Int. J. Oral Maxillofac. Surg. 34(1), 58–63 (2005)PubMedCrossRefGoogle Scholar
  13. 13.
    Trends in primary and secondary syphilis and HIV infections in men who have sex with men–San Francisco and Los Angeles, California, 1998–2002. MMWR Morb. Mortal Wkly. Rep. 53(26), 575–578 (2004)Google Scholar
  14. 14.
    Wong, W., Chaw, J.K., Kent, C.K., Klausner, J.D.: Risk factors for early syphilis among gay and bisexual men seen in an STD clinic: San Francisco, 2002–2003. Sex. Transm. Dis. 32(7), 458–463 (2005)PubMedCrossRefGoogle Scholar
  15. 15.
    Garnett, G.P., Aral, S.O., Hoyle, D.V., Cates Jr., W., Anderson, R.M.: The natural history of syphilis. Implications for the transmission dynamics and control of infection. Sex. Transm. Dis. 24(4), 185–200 (1997)PubMedCrossRefGoogle Scholar
  16. 16.
    Czelusta, A., Yen-Moore, A., Van der Straten, M., Carrasco, D., Tyring, S.K.: An overview of sexually transmitted diseases. Part III. Sexually transmitted diseases in HIV-infected patients. J. Am. Acad. Dermatol. 43(3), 409–432 (2000). quiz 33–6PubMedCrossRefGoogle Scholar
  17. 17.
    Baeten, J.M., Overbaugh, J.: Measuring the infectiousness of persons with HIV-1: opportunities for preventing sexual HIV-1 transmission. Curr. HIV Res. 1(1), 69–86 (2003)PubMedCrossRefGoogle Scholar
  18. 18.
    Quinn, T.C., Wawer, M.J., Sewankambo, N., et al.: Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai project study group. N Engl J. Med. 342(13), 921–929 (2000)PubMedCrossRefGoogle Scholar
  19. 19.
    Dyer, J.R., Eron, J.J., Hoffman, I.F., et al.: Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi. J. Infect. Dis. 177(1), 224–227 (1998)PubMedCrossRefGoogle Scholar
  20. 20.
    Mehta, S.D., Ghanem, K.G., Rompalo, A.M., Erbelding, E.J.: HIV seroconversion among public sexually transmitted disease clinic patients: analysis of risks to facilitate early identification. J. Acquir. Immune Defic. syndr. (1999) 42(1), 116–122 (2006)CrossRefGoogle Scholar
  21. 21.
    Fleming, D.T., Wasserheit, J.N.: From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex. Transm. Infect. 75(1), 3–17 (1999)PubMedCrossRefGoogle Scholar
  22. 22.
    Chesson, H.W., Pinkerton, S.D., Voigt, R., Counts, G.W.: HIV infections and associated costs attributable to syphilis coinfection among African Americans. Am. J. Public Health 93(6), 943–948 (2003)PubMedCrossRefGoogle Scholar
  23. 23.
    Hutchinson, C.M., Hook 3rd, E.W., Shepherd, M., Verley, J., Rompalo, A.M.: Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Ann. Intern. Med. 121(2), 94–100 (1994)PubMedGoogle Scholar
  24. 24.
    Rompalo, A.M., Joesoef, M.R., O’Donnell, J.A., et al.: Clinical manifestations of early syphilis by HIV status and gender: results of the syphilis and HIV study. Sex. Transm. Dis. 28(3), 158–165 (2001)PubMedCrossRefGoogle Scholar
  25. 25.
    Rompalo, A.M., Lawlor, J., Seaman, P., Quinn, T.C., Zenilman, J.M., Hook 3rd, E.W.: Modification of syphilitic genital ulcer manifestations by coexistent HIV infection. Sex. Transm. Dis. 28(8), 448–454 (2001)PubMedCrossRefGoogle Scholar
  26. 26.
    Inamadar, A.C., Palit, A.: Perforating chancre: any cause-effect relation with HIV infection? Sex. Transm. Infect. 79(3), 262 (2003)PubMedCrossRefGoogle Scholar
  27. 27.
    Little, J.W.: Syphilis: an update. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 100(1), 3–9 (2005)PubMedCrossRefGoogle Scholar
  28. 28.
    Hourihan, M., Wheeler, H., Houghton, R., Goh, B.T.: Lessons from the syphilis outbreak in homosexual men in east London. Sex. Transm. Infect. 80(6), 509–511 (2004)PubMedCrossRefGoogle Scholar
  29. 29.
    Angus, J., Langan, S.M., Stanway, A., Leach, I.H., Littlewood, S.M., English, J.S.: The many faces of secondary syphilis: a re-emergence of an old disease. Clin. Exp. Dermatol. 31(5), 741–745 (2006)PubMedCrossRefGoogle Scholar
  30. 30.
    D’Amico, R., Zalusky, R.: A case of lues maligna in a patient with acquired immunodeficiency syndrome (AIDS). Scand. J. Infect. Dis. 37(9), 697–700 (2005)PubMedCrossRefGoogle Scholar
  31. 31.
    Primary and secondary syphilis among men who have sex with men–New York City, 2001. MMWR Morb. Mortal Wkly Rep. 51(38):853–856 (2002)Google Scholar
  32. 32.
    Kent, M.E., Romanelli, F.: Reexamining syphilis: an update on epidemiology, clinical manifestations, and management. Ann. Pharmacother. 42(2), 226–236 (2008)PubMedCrossRefGoogle Scholar
  33. 33.
    Dourmishev, L.A., Dourmishev, A.L.: Syphilis: uncommon presentations in adults. Clin. Dermatol. 23(6), 555–564 (2005)PubMedCrossRefGoogle Scholar
  34. 34.
    Regal, L., Demaerel, P., Dubois, B.: Cerebral syphilitic gumma in a human immunodeficiency virus-positive patient. Arch. Neurol. 62(8), 1310–1311 (2005)PubMedCrossRefGoogle Scholar
  35. 35.
    Bleeker-Rovers, C.P., van der Ven, A.J., Zomer, B., et al.: F-18-fluorodeoxyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients. AIDS (London, England) 18(18), 2430–2432 (2004)Google Scholar
  36. 36.
    Marra, C.M., Gary, D.W., Kuypers, J., Jacobson, M.A.: Diagnosis of neurosyphilis in patients infected with human immunodeficiency virus type 1. J. Infect. Dis. 174(1), 219–221 (1996)PubMedCrossRefGoogle Scholar
  37. 37.
    Wohrl, S., Geusau, A.: Clinical update: syphilis in adults. Lancet 369(9577), 1912–1914 (2007)PubMedCrossRefGoogle Scholar
  38. 38.
    Katz, D.A., Berger, J.R., Duncan, R.C.: Neurosyphilis. A comparative study of the effects of infection with human immunodeficiency virus. Arch. Neurol. 50(3), 243–249 (1993)PubMedGoogle Scholar
  39. 39.
    Wheeler, H.L., Agarwal, S., Goh, B.T.: Dark ground microscopy and treponemal serological tests in the diagnosis of early syphilis. Sex. Transm. Infect. 80(5), 411–414 (2004)PubMedCrossRefGoogle Scholar
  40. 40.
    Malone, J.L., Wallace, M.R., Hendrick, B.B., et al.: Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapy. Am. J. Med. 99(1), 55–63 (1995)PubMedCrossRefGoogle Scholar
  41. 41.
    Radolf, J.D., Kaplan, R.P.: Unusual manifestations of secondary syphilis and abnormal humoral immune response to Treponema pallidum antigens in a homosexual man with asymptomatic human immunodeficiency virus infection. J. Am. Acad. Dermatol. 18(2 Pt 2), 423–428 (1988)PubMedCrossRefGoogle Scholar
  42. 42.
    Dowell, M.E., Ross, P.G., Musher, D.M., Cate, T.R., Baughn, R.E.: Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am. J. Med. 93(5), 481–488 (1992)PubMedCrossRefGoogle Scholar
  43. 43.
    Ghanem, K.G., Erbelding, E.J., Cheng, W.W., Rompalo, A.M.: Doxycycline compared with benzathine penicillin for the treatment of early syphilis. Clin. Infect. Dis. 42(6), e45–e49 (2006)PubMedCrossRefGoogle Scholar
  44. 44.
    Smith, N.H., Musher, D.M., Huang, D.B., et al.: Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin. Int. J. STD AIDS 15(5), 328–332 (2004)PubMedCrossRefGoogle Scholar
  45. 45.
    Lynn, W.A., Lightman, S.: Syphilis and HIV: a dangerous combination. Lancet Infect. Dis. 4(7), 456–466 (2004)PubMedCrossRefGoogle Scholar

Copyright information

© Springer Berlin Heidelberg 2011

Authors and Affiliations

  • Natalia Mendoza
    • 1
  • Adriana Motta
    • 2
  • Brenda L. Pellicane
    • 3
  • Parisa Ravanfar
    • 3
  • Stephen K. Tyring
    • 3
  1. 1.Center for Clinical StudiesUniversidad El BosqueBogotaColombia
  2. 2.Dermatology DepartmentUniversidad El BosqueBogotaColombia
  3. 3.Dermatology Department, Center for Clinical StudiesUniversity of TexasHoustonUSA

Personalised recommendations